Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Neoadjuvant registration study -Triple negative breast cancer.
Phase: 3Phase III in Spain, 2Phase II, 1Phase I